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ABST RACT

The incidence of rheumatic fever (RF) has markedly decreased in Europe
since the beginning of the 20th century due to improved living conditions,
early antibiotic therapy in streptococcal pharyngitis, and changes in
serotypes of circulating streptococci. Isolated outbreaks of RF are still found
in various parts of the world and the disease has changed its presentation
with milder joint symptoms and subclinical carditis that make the correct
diagnosis more difficult. Patients can present many years later with severe
valve disease and significant disability. This article presents a case of
isolated rheumatic tricuspid valve disease that presented with signs and
symptoms of right heart failure and severe valve damage. Isolated
involvement of the tricuspid valve is rarely found in rheumatic fever and a
thorough differential diagnosis is needed.

Introduction
The incidence of rheumatic fever (RF) and rheumatic
heart disease has decreased in Europe in the last century
due to improved living conditions, proper use of antibiotics
in streptococcal pharyngitis, and changes in streptococcal
serotypes. RF is a non-suppurative inflammation of
connective tissue that occurs as a late complication of a
pharyngeal infection caused by group A beta hemolytic
streptococcus (GABHS) in predisposed individuals. It is an
autoimmune disease, in which an intense humoral and
cellular mediated immune response (activated against the
streptococci) damages various organs. This is due to a
molecular mimicry between M protein and N acetyl
glucosamine from the bacterial wall and compounds like
vimentin (from synovial tissue), myosin and tropomyosin
(from myocardium), laminin (from heart valves), keratin
(form skin), or lysogangliosides (found in subthalamic and
caudal nuclei) of human host [1]. The disease occurs in
young patients typically aged 5-15 years. Individuals
expressing B cell alloantigen D8/17 or HLA- DR7 or HLAD8/17 have an increased risk of RF [2]. The affected
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organs are represented by heart, joints, central nervous
system, and skin. Heart involvement consists of the
occurrence of pancarditis. The only long-term sequel of
rheumatic fever is valve disease.
The microscopic changes seen in rheumatic valvulitis
vary over time; in the first weeks there is inflammatory cell
infiltration, breakdown of collagen fibrils, edema, and later
granuloma formation. The rheumatic granuloma is named
Aschoff body. The Aschoff body has a central area of
collagen necrosis surrounded by lymphocytes,
macrophages, giant multinuclear cells, and fibroblasts.
The granuloma will be replaced by a fibrous scar. Initial
valve damage can expose intracellular proteins to the
immune cells that will generate autoantibodies and lead to
continuing low grade inflammation. Persisting
inflammation and the trauma produced by the turbulent
blood flow contribute to the severe valve damage seen
many years after RF.
Inflammation preferentially affects the mitral and
aortic valves, possibly due to higher hemodynamic stress
on valve tissue, while tricuspid and pulmonary valves are
rarely involved. Although rare, isolated rheumatic
tricuspid valve disease can cause severe heart failure.
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Case Presentation
A 59-year-old male presented to the emergency
department for shortness of breath on mild exertion and
palpitations, symptoms that began 3 weeks earlier. He is a
chronic alcohol drinker but has no medical history. On
physical examination, mild peripheral edema was present,
breath sounds were abolished at both lung bases due to
pleural effusions, arterial oxygen saturation (SaO2) was
90%, heart rate was 130 beats/min with irregular heart
sounds, and a systolic murmur grade III/VI was heard in
the 4-5th intercostal spaces on the left sternal border and
accentuated with inspiration. Blood pressure was 130/80
mmHg, jugular veins were distended, and the liver was
enlarged and tender.
Blood analysis showed a high NT proBNP value of
2853 pg/ml, high D – dimer value of 2.86 µg/ml, normal
troponin T, high value of liver enzymes (ASAT=90 U,
ALAT= 48 U, gamma glutamyl transpeptidase= 417u),
with slight increase in both direct and indirect bilirubin
values; hepatic viral antigens were absent. Other blood
analyses were in the normal range.
ECG showed atrial fibrillation with fast heart rate (120
bpm), a QRS axis of +900, incomplete right bundle branch
block and QRS alternans in V1-V6 leads. Thoracic CT scan
found bilateral pleural effusions in moderate amount and
excluded pneumonia, lung tumor, or pulmonary embolism.
Transthoracic echocardiography (TTE) showed
significant structural changes in the tricuspid valve.
Anterior and posterior cusps were thickened, calcified, and
had restricted motion. Subvalvular chords were thickened.
Structural changes caused severe regurgitation (effective
regurgitant orifice area= 0.57 cm2, regurgitant volume= 45
ml) and moderate stenosis (high diastolic gradient of 13/6
mmHg which contributed to the high inflow accompanying
severe regurgitation). Right chambers were dilated with
right ventricle longitudinal systolic dysfunction (TAPSE=
16mm, S’value = 10 cm/s) and with dilated inferior vena
cava indicating increased pressure in the right atrium.
These aspects are shown in figures 1-5.

A 3D exam could have better described valve anatomy
including commissural fusion and could measure tricuspid
valve area by planimetry but was not available.
Small calcification spots were found on aortic cusps
causing mild aortic regurgitation, aspect shown in figure 6.
Figure 2

Figure 2. Parasternal short axis view- the anterior
cusp of the tricuspid valve is thickened and calcified,
chordae tendinae are thickened, right atrium is dilated
and a calcification area is found on the aortic right
coronary cusp.

Figure 3

Figure 3. Right ventricular inflow view- the anterior
and posterior cusps of the tricuspid valve have
massive calcifications.
Figure 4

Figure 1

Figure 1. Apical 4 chambers (A4C) view- thickened
tricuspid valve leaflets and dilated right heart chambers.

Figure 4. A4C Color Doppler - severe tricuspid
regurgitation.
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Figure 5

Figure 5. A4C CWD - the envelope of right
ventricular inflow with high gradients indicating
severe tricuspid stenosis and the envelope of severe
tricuspid regurgitation.
Figure 6

Figure 6. Mild aortic regurgitation.

Figure 7
Figure 7. ECG
Mitral valve had no structural changes. The left
ventricle had normal dimensions but diffuse hypokinesis
and reduced ejection fraction (35%). A small amount of
pericardial fluid was noticed.
The patient was diagnosed with isolated rheumatic
tricuspid valve disease (severe regurgitation and stenosis)
and heart failure. Left ventricle systolic dysfunction could
be toxic (alcohol) or due to tachycardia; other etiologies
like myocarditis or ischemia were improbable. He was
treated with beta-blocker, digoxin, diuretics, and anti130

coagulants. Edema and pleural effusions disappeared and
patient’s condition improved; also, the value of liver
enzymes became normal. The patient required surgical
correction of the tricuspid valve disease.
Rheumatic tricuspid valve disease should be
differentiated from other diseases like carcinoid syndrome
(which causes valve thickening with “frozen” aspect),
congenital tricuspid regurgitation/stenosis (due to various
anomalies of cusps like cleft or hypoplasia, anomalies of
chordae like short, elongated or abnormally inserted,
or anomalies of commissures COMMISSURAL
ANOMALIES etc.), or valve damage due to drugs (which
cause valve fibrosis), but calcifications are not seen in these
etiologies [3]. Radiation therapy causes valve fibrosis and
calcification but not commissural fusion.

Discussions
The incidence of rheumatic fever has decreased since
the 1900s in many regions including Europe, due to
improved living conditions, early diagnosis and therapy of
pharyngitis, and change in streptococcal virulence. The
disease has shown an unexpected revival as isolated
outbreaks of RF caused by virulent serotypes reported
worldwide. A recent review shows an increasing trend in
RF incidence in the Americas and Western Pacific, in
Eastern Mediterranean and Asia, a constant decrease in
Africa, and a decrease in Europe. The prevalence of
rheumatic heart disease is increasing in all parts of the
world with the exception of Europe [2,3].
Only 0.3-3% of patients with pharyngitis develop
rheumatic fever, 40-60% of them will have carditis, and
60% will develop rheumatic heart disease and have an
increased risk of arrhythmia, embolic complications and
heart failure [4].
The diagnosis of rheumatic fever is done using the
Jones criteria that have been modified several times over
the last 6 decades. There are both major criteria (migratory
polyarthritis, clinical or subclinical carditis, chorea,
erythema marginatum and subcutaneous nodules) and
minor criteria (polyarthralgia, fever, long PR interval, high
value of inflammation markers, history of previous episode
of RF or rheumatic heart disease). The third criterion is the
proof of preceding GABHS infection provided by
increasing titers of anti-streptococcal antibodies or
isolation of GABHS in throat culture or positive rapid
GABHS carbohydrate antigen test in a child.
Echocardiography has a substantial contribution to the
diagnosis of subclinical carditis.
The 2015 AHA revision of Jones criteria clarified
specific parameters. Low risk population is considered if
there are fewer than 2 cases of RF per 100,000 school aged
children per year and less than 1 case with rheumatic heart
disease per 1000 population per year [5]. The classical
algorithm for the diagnosis of RF remains unchanged for
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low risk populations: the need for the presence 2 major
criteria, or 1 major and 2 minor criteria, together with the
evidence of recent streptococcal infection. For recurrent
RF, the presence of 3 minor criteria is also diagnostic. In
moderate and high-risk populations, monoarthritis and
polyarthralgia are major criteria, while monoarthralgia is
considered a minor criteria. Fever should be more than
38.50C in low risk and more than 380C in high risk
populations. ESR should be more than 60 mm/h in low risk
and more than 30 mm/h in moderate and high risk
populations, while C reactive protein should be more than
3mg/dl in all patients [5].
RF rarely affects right heart valves. Primary right heart
valve disease is found in 1.2% of patients with valve
disease according to Euro Heart Survey [6] and rheumatic
etiology can comprise up to a third of cases. The
prevalence of rheumatic tricuspid valve disease varies in
different parts of the world. In India tricuspid valve disease
was diagnosed in 9% of patients with rheumatic disease,
the mean age of patients was 24.2± 13.6 years [7]. Half of
the cases had combined stenosis and regurgitation and half
had isolated regurgitation.
In Europe, Bernal evaluated 328 patients with
rheumatic tricuspid valve disease referred for surgery
during a 30 year period and found that only 3.65% of cases
had isolated tricuspid valve disease, while the majority had
triple valve disease (60%) or double valve disease (33%),
most commonly mitral and tricuspid disease [8]. Patients
had a mean age of 51.3 ± 13.6years. The majority (72%)
had tricuspid regurgitation. Valve repair was achieved in
most cases (90.5%), and the in-hospital mortality was 7.6%
[8].
Our case is unusual because the patient did not have a
classical episode of RF, the diagnosis was late when
complications occurred and because of isolated tricuspid
damage. The patient needed tricuspid valve replacement
with a prosthesis. Data in the literature show that tricuspid
valve replacement has a higher immediate and midterm
mortality compared with valve repair (consisting of
commissurotomy and flexible or suture annuloplasty).
Recurrent tricuspid regurgitation is more common after
valve repair. A recent review found similar percentages of
patients with rheumatic tricuspid valve disease treated with
valve repair or replacement [9].
Both biological and mechanical prosthesis are good
choices for the tricuspid valve, patients having similar
early and late survival and similar re-operation rates.
According to Rizzoli, the tricuspid valve makes no
exception to the rule that patients older than 65-70 years
benefit more from bio-prosthesis while younger ones from
mechanical valves [10, 11].

Highlights
✓ Although the incidence of rheumatic heart disease is
decreasing, in practice rheumatic valve damage still
presents in a variety of scenarios and the management
of cases remains a challenge.
✓ Transthoracic echocardiography has a key role in
diagnosing tricuspid valve disease.

Conclusions
Rheumatic valve disease continues to cause significant
morbidity despite health programs of early diagnosis and
therapy of streptococcal infections. Isolated rheumatic
tricuspid valve damage can cause severe heart failure.
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